What We're Reading: Page 192
Industry reads hand-picked by our editors
Oct 14, 2020
-
Reuters
FDA faults quality control at Lilly plant making Trump-touted COVID drug
-
STAT
Selling stock at a clip, top Moderna doctor gets $1 million richer each week
-
FierceBiotech
Cyclerion fails sickle cell test, prompting pivot to CNS disease
-
Politico
FDA pushes back on Trump administration attempt to rebrand 'emergency authorization'
Oct 13, 2020
-
The New York Times
The Race for a Super-Antibody Against the Coronavirus
-
STAT
How would doctors and insurers navigate demand for a new, narrow Alzheimer's drug?
-
In the Pipeline
Another Vaccine Trial Halt
Oct 12, 2020
-
Politico
Pfizer trying to defuse critics amid push for vaccine before Election Day
-
Wired
Trump's 'Miracle Cure' for Covid Is a Logistical Nightmare
-
Barron's
Pfizer Suit Could Be an 'Earthquake' for Drug Pricing
-
FierceBiotech
You've met Moderna, BioNTech and Curevac. Now meet Kernal Bio, the startup working on mRNA 2.0
Oct 09, 2020
Oct 08, 2020
Oct 07, 2020
-
STAT
Two female CRISPR scientists make history, winning Nobel Prize in chemistry for genome-editing discovery
-
Bloomberg
FDA Will Force Vaccine-Safety Disclosures If Makers Don't
-
Politico
HHS whistleblower Rick Bright resigns from government
-
Endpoints News
Roche joins AbbVie in stepping on Vertex's turf, betting $96M on an alternative CF approach
Oct 06, 2020
-
Reuters
Moderna vaccine trial contractors fail to enroll enough minorities, prompting slowdown
-
MarketWatch
Iovance's stock tumbles over questions about regulatory submission for melanoma drug
-
The Wall Street Journal
Covid-19 Vaccine Delivery Will Present Tough Challenge to Cargo Airlines
-
San Francisco Business Times
Startup from UC Berkeley CRISPR pioneer Jennifer Doudna lands ALS deal with Biogen
Previous
